Izinkomba zokusebenzisa (chaza)
Evutha ama-viroshereszenzelwe ukuthi zisetshenziselwe ukwakheka kwezimali ze-artteriovenous (AVMS) kanye nama-hypervascular tumors, kufaka phakathi ama-fibroids e-Uterine.
Igama elijwayelekile noma elivamile
Igama: Idivayisi ye-Vascular Embolization
Ukuhlukaniswa: Isigaba II
Iphaneli: Cardiovascular
Ukuchazayo
I-EMBOLICOCICHERES iyacindezelwa ama-hydrogel microspheres angcolile anesimo esijwayelekile, ubushelelezi obushelelezi, nosayizi olinganiselwe, olwakhiwe ngenxa yokuguqulwa kwamakhemikhali nge-polyvinyl alcohol (PVA) izinto. I-EMBOLICOSICSHERES iqukethe i-macromer ethathwe ku-polyvinyl alcohol (PVA), futhi iyi-hydrophilic, engahlehli, futhi iyatholakala osayizi. Isixazululo sokulondolozwa yi-0.9% sodium chloride solution. Okuqukethwe kwamanzi kwama-polymerised microsphere kungama-91% ~ 94%. Ama-Microspheres angabekezelela ukucindezelwa kwama-30%.
I-EMBOOCICHERES iyahlinzekwa ngenyumba futhi ihlanganiswe ezindaweni ezivalekile zengilazi.
I-EMBOLICOCICREES ye-EMBOLICOS ihloselwe ukusetshenziselwa ukwakheka kwezimali ze-artteriovenous (AVMS) kanye nama-hypervascular tumors, kufaka phakathi ama-fibroids e-Uterine. Ngokuvimba ukulethwa kwegazi endaweni okuhlosiwe, isimila noma ukungahambi kahle kubulawa yindlala futhi kuncipha ngosayizi.
I-EMBOLICOCICOSTES ingahanjiswa ngama-microcatheter ajwayelekile kuhlu lwe-1.7- 4. Ngesikhathi sokusebenzisa, ama-microsheres e-egolic ahlanganiswe ne-ejenti ye-nonion ehlukile ukwakha ikhambi lokumiswa. I-egolicos microsies ihloselwe ukusetshenziswa okukodwa futhi ihlinzekwa inzalo futhi engeyona eye-pyrogenic. Ukucushwa kwedivayisi kwe-emboc acroster kuchazwe kuThebula 1 naseThebula 2 ngezansi.
Phakathi kosayizi ahlukahlukene we-erough timosperes e-ebocting, ubungako obukhulu obungasetshenziselwa ukwakheka kwe-Uterine Fibroid ngama-500-700μm, 700-900μm no-900-1200μm.
Ithebula: Ukucushwa kwedivayisi kwe-ebocring microsheres | ||||
Umphumela Ukufingqwa | -Lingene Usayizi (μm) | Ubuningi | Inkomba | |
Ama-Hypervascular Tumors / Arteriovenous Ukusebenzisekahle | Uterine Fibroid | |||
B107S103 | 100-300 | I-1ML Microsrosheres: 7mL 0.9% sodium chloride | Yebo | No |
B107S305 | 300-500 | I-1ML Microsrosheres: 7mL 0.9% sodium chloride | Yebo | No |
B107S507 | 500-700 | I-1ML Microsrosheres: 7mL 0.9% sodium chloride | Yebo | Yebo |
B107S709 | 700-900 | I-1ML Microsrosheres: 7mL 0.9% sodium chloride | Yebo | Yebo |
B107S912 | 900-1200 | I-1ML Microsrosheres: 7mL 0.9% sodium chloride | Yebo | Yebo |
B207S103 | 100-300 | 2ml microsmares: 7ml 0.9% sodium chloride | Yebo | No |
B207S305 | 300-500 | 2ml microsmares: 7ml 0.9% sodium chloride | Yebo | No |
B207S507 | 500-700 | 2ml microsmares: 7ml 0.9% sodium chloride | Yebo | Yebo |
B207S709 | 700-900 | 2ml microsmares: 7ml 0.9% sodium chloride | Yebo | Yebo |
B207S912 | 900-1200 | 2ml microsmares: 7ml 0.9% sodium chloride | Yebo | Yebo |
Umphumela Ukufingqwa | -Lingene Usayizi (μm) | Ubuningi | Inkomba | |
Ama-Hypervascular Tumors / Arteriovenous Ukusebenzisekahle | Uterine Fibroid | |||
U107S103 | 100-300 | I-1ML Microsrosheres: 7mL 0.9% sodium chloride | Yebo | No |
U107S305 | 300-500 | I-1ML Microsrosheres: 7mL 0.9% sodium chloride | Yebo | No |
U107S507 | 500-700 | I-1ML Microsrosheres: 7mL 0.9% sodium chloride | Yebo | Yebo |
U107S709 | 700-900 | I-1ML Microsrosheres: 7mL 0.9% sodium chloride | Yebo | Yebo |
U107S912 | 900-1200 | I-1ML Microsrosheres: 7mL 0.9% sodium chloride | Yebo | Yebo |
U207S103 | 100-300 | 2ml microsmares: 7ml 0.9% sodium chloride | Yebo | No |
U207S305 | 300-500 | 2ml microsmares: 7ml 0.9% sodium chloride | Yebo | No |
U207S507 | 500-700 | 2ml microsmares: 7ml 0.9% sodium chloride | Yebo | Yebo |
U207S709 | 700-900 | 2ml microsmares: 7ml 0.9% sodium chloride | Yebo | Yebo |
U207S912 | 900-1200 | 2ml microsmares: 7ml 0.9% sodium chloride | Yebo | Yebo |
Isikhathi sePosi: Feb-27-2024